Search Results - "Jebsen, Nina L"

External Beam Radiation Therapy for Resectable Soft Tissue Sarcoma: A Systematic Review and Meta-Analysis by Albertsmeier, Markus, Rauch, Alexandra, Roeder, Falk, Hasenhütl, Sandro, Pratschke, Sebastian, Kirschneck, Michaela, Gronchi, Alessandro, Jebsen, Nina L., Cassier, Philippe A., Sargos, Paul, Belka, Claus, Lindner, Lars H., Werner, Jens, Angele, Martin K.

“…Purpose The aim of this study was to evaluate the role of preoperative and postoperative external beam radiation therapy (EBRT) in the treatment of resectable…”
Get full text

Radiotherapy to Improve Local Control Regardless of Surgical Margin and Malignancy Grade in Extremity and Trunk Wall Soft Tissue Sarcoma: A Scandinavian Sarcoma Group Study by Jebsen, Nina L., M.D, Trovik, Clement S., M.D., Ph.D, Bauer, Henrik C.F., M.D., Ph.D, Rydholm, Anders, M.D, Ph.D, Monge, Odd R., M.D, Hall, Kirsten Sundby, M.D., Ph.D, Alvegård, Thor, M.D., Ph.D, Bruland, Øyvind S., M.D., Ph.D

“…Purpose Adjuvant radiotherapy has during the past decades become increasingly used in the treatment of localized soft tissue sarcoma. We evaluated the effect…”
Get full text

Patterns of Local Recurrence and Dose Fractionation of Adjuvant Radiation Therapy in 462 Patients With Soft Tissue Sarcoma of Extremity and Trunk Wall by Jebsen, Nina L., MD, Engellau, Jacob, MD, PhD, Engström, Katarina, MD, PhD, Bauer, Henrik C., MD, PhD, Monge, Odd R., MD, Muren, Ludvig P., PhD, Eide, Geir E., MSc, PhD, Trovik, Clement S., MD, PhD, Bruland, Øyvind S., MD, PhD

“…Purpose To study the impact of dose fractionation of adjuvant radiation therapy (RT) on local recurrence (LR) and the relation of LR to radiation fields…”
Get full text

Five-Year Results From a Scandinavian Sarcoma Group Study (SSG XIII) of Adjuvant Chemotherapy Combined With Accelerated Radiotherapy in High-Risk Soft Tissue Sarcoma of Extremities and Trunk Wall by Jebsen, Nina L., M.D, Bruland, Øyvind S., M.D., Ph.D, Eriksson, Mikael, M.D., Ph.D, Engellau, Jacob, M.D., Ph.D, Turesson, Ingela, M.D., Ph.D, Folin, Annika, M.D, Trovik, Clement S., M.D., Ph.D, Hall, Kirsten Sundby, M.D., Ph.D

“…Purpose To evaluate adjuvant chemotherapy and interpolated accelerated radiotherapy (RT) for adult patients with high-risk soft tissue sarcoma in the…”
Get full text

Exploring the Patient Perspective of Bone Sarcoma Survivors Who Have Undergone Particle Radiotherapy Abroad by Fauske, Lena, Jebsen, Nina L, Bondevik, Hilde, Bruland, Øyvind S

“…Sarcoma patients' experiences of their health-related quality of life and late effects following particle therapy are sparse. Such knowledge is essential to…”
Get more information

EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma by Ferrari, Stefano, Bielack, Stefan S., Smeland, Sigbjørn, Longhi, Alessandra, Egerer, Gerlinde, Sundby Hall, Kirsten, Donati, Davide, Kevric, Matthias, Brosjö, Otte, Comandone, Alessandro, Werner, Mathias, Monge, Odd, Palmerini, Emanuela, Berdel, Wolfgang E., Bjerkehagen, Bodil, Paioli, Anna, Lorenzen, Sylvie, Eriksson, Mikael, Gambarotti, Marco, Tunn, Per-Ulf, Jebsen, Nina L., Cesari, Marilena, von Kalle, Thekla, Ferraresi, Virginia, Schwarz, Rudolf, Bertulli, Rossella, Kasparek, Anne-Katrin, Grignani, Giovanni, Krasniqi, Fatime, Sorg, Benjamin, Hecker-Nolting, Stefanie, Picci, Piero, Reichardt, Peter

“…Introduction: The EUROpean Bone Over 40 Sarcoma Study (EURO-B.O.S.S.) was the first prospective international study for patients 41-65 years old with…”
Get full text

Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: A Nonrandomized Controlled Trial by Lansu, Jules, Bovée, Judith V M G, Braam, Pètra, van Boven, Hester, Flucke, Uta, Bonenkamp, Johannes J, Miah, Aisha B, Zaidi, Shane H, Thway, Khin, Bruland, Øyvind S, Baldini, Elizabeth H, Jebsen, Nina L, Scholten, Astrid N, van den Ende, Piet L A, Krol, Augustinus D G, Ubbels, Jan F, van der Hage, Jos A, van Werkhoven, Erik, Klomp, Houke M, van der Graaf, Winette T A, van Coevorden, Frits, Schrage, Yvonne, van Houdt, Winan J, Haas, Rick L

“…Currently, preoperative radiotherapy for all soft-tissue sarcomas is identical at a 50-Gy dose level, which can be associated with morbidity, particularly…”
Get more information

Adjuvant radiotherapy in retroperitoneal sarcomas. A Scandinavian Sarcoma Group study of 97 patients by Trovik, Linn H, Ovrebo, Kjell, Almquist, Martin, Haugland, Hans Kristian, Rissler, Pehr, Eide, Johan, Engellau, Jacob, Monge, Odd R, Nyhus, Anniken B, Elde, Ingvild K, Jebsen, Nina L

“…Currently there is no consensus on the use of adjuvant radiotherapy (RT) in retroperitoneal sarcoma (RPS). We have analysed clinical outcomes in patients with…”
Get more information

Validation of a novel risk score to predict early and late recurrence in solitary fibrous tumour by Georgiesh, Tatiana, Aggerholm-Pedersen, Ninna, Schöffski, Patrick, Zhang, Yifan, Napolitano, Andrea, Bovée, Judith V. M. G., Hjelle, Åse, Tang, Gordon, Spalek, Mateusz, Nannini, Margherita, Swanson, David, Baad-Hansen, Thomas, Sciot, Raf, Hesla, Asle C., Huang, Paul, Dorleijn, Desiree, Haugland, Hans Kristian, Lacambra, Maribel, Skoczylas, Jacek, Pantaleo, Maria A., Haas, Rick L., Meza-Zepeda, Leonardo A., Haller, Florian, Czarnecka, Anna M., Loong, Herbert, Jebsen, Nina L., van de Sande, Michiel, Jones, Robin L., Haglund, Felix, Timmermans, Iris, Safwat, Akmal, Bjerkehagen, Bodil, Boye, Kjetil

“…Background Current risk models in solitary fibrous tumour (SFT) were developed using cohorts with short follow-up and cannot reliably identify low-risk…”
Get full text

Abstract CT010: A phase I study of the oncolytic peptide LTX-315 generates de novo T-cell responses and clinical benefit in patients with advanced sarcoma by Baaurain, Jean-Francois, Jungels, Christiane, Kristeleit, Rebecca S., Jossang, Dag E., Jebsen, Nina L., Rekdal, Øystein, Sveinbjornsson, Baldur, Gjerstad, Vibeke S., Brunsvig, Paal, Galon, Jerome, Hermitte, Fabienne, Patel, Hamina

“…Abstract Background: LTX-315 is a first-in class oncolytic peptide that has the ability to kill cancer cells and induce specific anticancer immune response…”
Get full text

Abstract CT069: A Phase I study of the oncolytic peptide LTX-315 generates de novo T-cell responses and clinical benefit in patients with advanced melanoma by Marabelle, Aurelien, Baurain, Jean-Francois, Awada, Ahmad, Kristeleit, Rebbecca S., Loirat, Delphine, Jossang, Dag E., Jebsen, Nina L., Sveinbjornsson, Baldur, Rekdal, Øystein, Gjerstad, Vibeke S., Brunsvig, Paal, Galon, Jerome, Hermitte, Fabienne, Patel, Hamina, Spicer, James

“…Abstract Background: LTX-315 is a first-in class oncolytic peptide that has the ability to kill cancer cells and induce specific anticancer immune response…”
Get full text

Abstract A08: Disease monitoring by liquid biopsies in sarcomas by Namløs, Heidi M., Moosavi, Seyed Hossein, Lorenz, Susanne, Bjerkehagen, Bodil, Zaikova, Olga, Granlien, Synnøve, Næss, Stine, Stratford, Eva, Munthe, Else, Aasheim, Lars B., Nakken, Sigve, Hovig, Eivind, Jebsen, Nina L., Hall, Kirsten Sundby, Mishkin, Skyler, Kudlow, Brian, Myklebost, Ola, Boye, Kjetil, Meza-Zepeda, Leonardo A.

“…Abstract The CircSarc study aims to provide new insights into the clinical utility of liquid biopsies in sarcomas. Today, mutational profiles of solid tumors…”
Get full text

Five-year results from a Scandinavian sarcoma group study (SSG XIII) of adjuvant chemotherapy combined with accelerated radiotherapy in high-risk soft tissue sarcome of extremities and trunk wall by Jebsen, Nina L., Bruland, Oyvind S., Eriksson, Mikael, Engellau, Jacob, Turesson, Ingela, Folin, Annika, Trovik, Clement S., Hall, Kirsten Sundby

“…Purpose: To evaluate adjuvant chemotherapy and interpolated accelerated radiotherapy (RT) for adult patients with high-risk soft tissue sarcoma in the…”
Get full text

Treatment of patients with gastrointestinal stromal tumour with imatinib mesylate by Haugland, Hans K, Jebsen, Nina L, Mannelqvist, Monica, Skar, Robert, Eide, Johan, Øvrebø, Kjell, Horn, Arild, Jensen, Dag K, Monge, Odd R, Lilleng, Peer K

“…Gastrointestinal stromal tumour (GIST) is the most frequent mesenchymal tumour type of the digestive tract. Between 30 and 40% of patients have high-risk,…”
Get full text

Behandling med imatinibmesylat av pasienter med gastrointestinal stromal tumor by Haugland, Hans K, Jebsen, Nina L, Mannelqvist, Monica, Skar, Robert, Eide, Johan, Øvrebø, Kjell, Horn, Arild, Jensen, Dag K, Monge, Odd R, Lilleng, Peer Kåre

“…Inneholder sammendrag…”
Get full text